Growing Financial Burden From High-Cost Targeted Oral Anticancer Medicines Among Medicare Beneficiaries With Cancer.
JCO oncology practice（2022）
摘要
The high and growing burden from TOAMs highlighted the need for reining in drug prices and capping out-of-pocket spending.
更多查看译文
关键词
oral anticancer medicines,medicare beneficiaries,financial burden,high-cost
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要